At the news
? BULLISHIMPACT 5/10 6-K filed Jun 24, 2026 at 21:34 ET
Mesoblast drew down US$50 million from a five-year non-dilutive facility provided by director Dr. Gregory George, at a fixed 8.00% interest rate secured solely by the Temcell royalty. The company also held US$122 million cash as of March 30, 2026, and plans to retire higher-cost short-term debt from NovaQuest, strengthening its balance sheet for commercial operations and pipeline growth.
- Drew down US$50 million from a five-year non-dilutive facility
- Fixed interest rate of 8.00% per annum with five-year interest-only period
- Facility secured solely by the Temcell royalty; no material assets or IP encumbered
- US$122 million cash at March 30, 2026
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access